Created with Sketch.
The MM+M Podcast
43 minutes | a month ago
Episode 74: Post-election analysis from a trio of healthcare policy pros
With election results hanging in the balance a day after the US election, Coalition for Healthcare Communication's Jon Bigelow, GWU's Dora Hughes and Alexion's Tamar Thompson explain what we can expect for healthcare under two very different presidential scenarios.
27 minutes | a month ago
Episode 73: Genentech's Quita Highsmith
Genentech isn’t currently developing a SARS-CoV-2 vaccine or therapeutic, but the biotech has been conducting research that could bring insight to bear on the willingness among communities of color to engage in clinical trials for COVID-19 vaccines and treatments. Quita Highsmith, Genentech’s chief diversity officer, speaks about that, and the biotech’s own efforts to recruit and instill more trust among underserved and medically disenfranchised patients.
37 minutes | a month ago
Episode 72: Deloitte's David Betts and Chris Zant
Deloitte's David Betts and Chris Zant join MM+M's Larry Dobrow to discuss the evolution in the way consultancies like Deloitte are working with life-sciences clients.
28 minutes | 2 months ago
Episode 71: FDA's Bakul Patel
Bakul Patel, who has been leading regulatory and scientific efforts related to digital health devices at the FDA since 2010, speaks about the agency’s new Digital Health Center of Excellence, his goals for the center and how it sets the stage for advancing and realizing the potential of digital health. He also shares progress in the FDA’s digital health pre-cert pilot.
38 minutes | 3 months ago
Episode 68: Alexion Pharmaceuticals' Tamar Thompson
Tamar Thompson, VP of government affairs and policy at Alexion Pharmaceuticals, speaks with Marc Iskowitz about how the biotech company, which recently appointed its first chief diversity officer, has evolved on the D&I front and how she personally became involved in spearheading efforts to boost ethnic and gender equity in its workforce and clinical trials.
31 minutes | 3 months ago
Marketers@Home Podcast Episode 5: Antares Pharma's Salvatore Paolozza
Salvatore Paolozza, Sr director, sales ops, Antares Pharma, speaks about ways he's leveraged technology to ensure Antares' reps maintain contact with doctors, as well as ways the firm is supporting HCPs as the healthcare system accommodates more online visits.
44 minutes | 3 months ago
Episode 67: Meredith's John Kenyon
John Kenyon, head of Meredith's Targeted Media Health unit, discusses the launch of People en Espanol Salud and the company's huge investment in the point-of-care space.
26 minutes | 3 months ago
Episode 66: Vaccine advocate Ethan Lindenberger
Marc Iskowitz, MM&M executive editor, speaks with world-renowned vaccine advocate Ethan Lindenberger about how COVID-19 has led to a surge in vaccine misinformation online, social media's efforts to quell its spread, as well as how the trend may impact medical marketers' promotion of an eventual COVID-19 vaccine.
46 minutes | 4 months ago
Episode 65: SK Life Science's Sebby Borriello
In this week's episode of The MM&M Podcast, Sebby Borriello, VP and chief commercial officer of SK Life Science, details his company's experience launching Xcopri, an epilepsy drug, during the COVID-19 crisis.
31 minutes | 4 months ago
Episode 64: PatientPoint's Linda Ruschau
PatientPoint's Linda Ruschau shares her thoughts on the recent evolution of the point-of-care space.
41 minutes | 4 months ago
Episode 63: Pascale Communications' Amy Houck and Vivvi Britton
Pascale Communications' Amy Houck and Vivvi Britton join MM&M's Larry Dobrow to discuss LinkedIn's evolution as an A-list vehicle for health marketers.
30 minutes | 4 months ago
Episode 62: Phreesia's David Linetsky
Phreesia's David Linetsky reveals how the point-of-care space adapted its offerings for the coronavirus era in this week's episode of The MM&M Podcast.
39 minutes | 5 months ago
Episode 61: WebMD's Dr. John Whyte
WebMD's Dr. John Whyte returns to The MM&M Podcast to discuss his company's ongoing coverage of the COVID-19 pandemic.
25 minutes | 5 months ago
Episode 60: TBWA\WorldHealth's #BlackHealthNow team
Walter Geer III, SVP, group creative director, digital experience + innovation, TBWA\WorldHealth, Wallye Holloway, associate managing partner, TBWA\WorldHealth and Bryan Gaffin, executive creative director, WildType head up the TBWA\WorldHealth social initiative #BlackHealthNow. The three agency execs speak with Marc Iskowitz, MM&M executive editor, about why they started a conversation about black health, the philosophy behind their unique programming, and what it’s like to be driving this important effort amid the COVID-19 pandemic and as our nation grapples with racism.
30 minutes | 5 months ago
Marketers@Home Episode 4: Siemens Healthineers' Deepak Nath
Deepak Nath, PhD, president of lab diagnostics for Siemens Healthineers, talks with Marc Iskowitz, MM&M executive editor, about the approach to promoting SARS-CoV-2 antibody testing amid unknowns about its immunity-determining potential, plus his firm’s future plans for educating an expanded group of stakeholders about such testing.
25 minutes | 6 months ago
Episode 59: Bayer's Sebastian Guth
Bayer's president of pharmaceuticals, Americas Region Sebastian Guth joins The MM&M Podcast for the second time to talk preserving culture and engagement during the COVID-19 pandemic.
27 minutes | 6 months ago
Episode 58: Fingerpaint's Bo Goliber
Fingerpaint head of philanthropy Bo Goliber joins MM&M's Larry Dobrow to discuss her company's virtual internship program and how the virtualization of agency life during COVID-19 has profound implications for the future of work.
33 minutes | 6 months ago
Episode 57: 2020 Agency 100 Preview
MM&M's Steve Madden, Marc Iskowitz, Sean Ayling and Larry Dobrow serve up a preview of this year's Agency 100 report, including the big cover reveal, a look at agency-world trends and a glance ahead at a potential post-Covid landscape.
31 minutes | 6 months ago
Episode 56: Evoke KYNE's Kate Callan
Evoke Kyne's EVP, head of social media Kate Callan joins MM&M's Larry Dobrow to discuss social media in the era of COVID-19 and how clients have adapted their tone and content.
32 minutes | 7 months ago
MM&M Marketers@Home Podcast Episode 3: AppliedVR's Everett Crosland
Everett Crosland, SVP of commercial for digital therapeutics firm AppliedVR, offers his take on how various aspects of market access for digital therapeutics are being transformed in the wake of coronavirus. This is the third in a series of MM&M podcasts called Marketers@Home, which looks at how healthcare marketers are adjusting to COVID-19. Listen to the first two in the series on our podcast page.
Terms of Service
© Stitcher 2020